|
US3172546A
(en)
|
1961-05-19 |
1965-03-09 |
Union Carbide Corp |
Size reduction of biological substances
|
|
US4133814A
(en)
|
1975-10-28 |
1979-01-09 |
Eli Lilly And Company |
2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
|
|
IT1082518B
(it)
|
1977-01-25 |
1985-05-21 |
Fiat Spa |
Specchio a cristallo liquido da impiegare particolarmente come retrovisore per veicoli
|
|
US4380635A
(en)
|
1981-04-03 |
1983-04-19 |
Eli Lilly And Company |
Synthesis of acylated benzothiophenes
|
|
US4418068A
(en)
|
1981-04-03 |
1983-11-29 |
Eli Lilly And Company |
Antiestrogenic and antiandrugenic benzothiophenes
|
|
DK150008C
(da)
|
1981-11-20 |
1987-05-25 |
Benzon As Alfred |
Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
|
|
DE3312671A1
(de)
|
1983-04-08 |
1984-10-11 |
Heinz Finzer KG, 7880 Bad Säckingen |
Stanz- und biegewerkzeug-aggregat
|
|
IT1227626B
(it)
|
1988-11-28 |
1991-04-23 |
Vectorpharma Int |
Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
|
|
JP2642486B2
(ja)
|
1989-08-04 |
1997-08-20 |
田辺製薬株式会社 |
難溶性薬物の超微粒子化法
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
AU660852B2
(en)
|
1992-11-25 |
1995-07-06 |
Elan Pharma International Limited |
Method of grinding pharmaceutical substances
|
|
US5298262A
(en)
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
|
US5336507A
(en)
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
|
BR9500758A
(pt)
|
1994-03-02 |
1995-10-24 |
Lilly Co Eli |
Formulaçoes farmacêuticas para administraçao oral
|
|
US5500331A
(en)
|
1994-05-25 |
1996-03-19 |
Eastman Kodak Company |
Comminution with small particle milling media
|
|
US5478705A
(en)
|
1994-05-25 |
1995-12-26 |
Eastman Kodak Company |
Milling a compound useful in imaging elements using polymeric milling media
|
|
US5631369A
(en)
|
1994-08-31 |
1997-05-20 |
Eli Lilly And Company |
Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
|
|
US5534270A
(en)
|
1995-02-09 |
1996-07-09 |
Nanosystems Llc |
Method of preparing stable drug nanoparticles
|
|
US5591456A
(en)
|
1995-02-10 |
1997-01-07 |
Nanosystems L.L.C. |
Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
IE80467B1
(en)
|
1995-07-03 |
1998-07-29 |
Elan Corp Plc |
Controlled release formulations for poorly soluble drugs
|
|
TW487582B
(en)
|
1995-08-11 |
2002-05-21 |
Nissan Chemical Ind Ltd |
Method for converting sparingly water-soluble medical substance to amorphous state
|
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
|
US6458811B1
(en)
|
1996-03-26 |
2002-10-01 |
Eli Lilly And Company |
Benzothiophenes formulations containing same and methods
|
|
US6713494B1
(en)
|
1996-08-28 |
2004-03-30 |
Eli Lilly And Company |
Amorphous benzothiophenes, methods of preparation and methods of use
|
|
WO1998035666A1
(en)
|
1997-02-13 |
1998-08-20 |
Nanosystems Llc |
Formulations of nanoparticle naproxen tablets
|
|
EP1007049A1
(en)
|
1997-08-27 |
2000-06-14 |
Hexal AG |
New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
|
|
US6165506A
(en)
|
1998-09-04 |
2000-12-26 |
Elan Pharma International Ltd. |
Solid dose form of nanoparticulate naproxen
|
|
JP2000095674A
(ja)
|
1998-09-22 |
2000-04-04 |
Sato Pharmaceutical Co Ltd |
口腔内崩壊時間短縮化錠剤の製造方法及び装置
|
|
US20040013613A1
(en)
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
EP1066825A1
(en)
|
1999-06-17 |
2001-01-10 |
The Procter & Gamble Company |
An anti-microbial body care product
|
|
DE19932157A1
(de)
|
1999-07-13 |
2001-01-18 |
Pharmasol Gmbh |
Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
EP2266549B1
(en)
|
2000-06-27 |
2019-08-07 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
|
EP1313451B1
(en)
|
2000-08-31 |
2009-03-11 |
Jagotec AG |
Milled particles
|
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
EP1341521B1
(en)
|
2000-11-20 |
2009-01-07 |
Elan Pharma International Limited |
Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
|
DK1920763T3
(da)
|
2000-11-30 |
2014-07-07 |
Vectura Ltd |
Farrmaceutiske præparater til inhalation
|
|
AU2002232492A1
(en)
|
2000-12-06 |
2002-06-18 |
Pharmacia Corporation |
Rapidly dispersing pharmaceutical composition comprising effervescent agents
|
|
FI20010115A0
(fi)
|
2001-01-18 |
2001-01-18 |
Orion Corp |
Menetelmä nanopartikkelien valmistamiseksi
|
|
US20020187187A1
(en)
*
|
2001-04-21 |
2002-12-12 |
Toshimitsu Ohki |
Fast disintegrating meloxicam tablet
|
|
DE60203506T2
(de)
|
2001-06-22 |
2006-02-16 |
Marie Lindner |
Screening-verfahren mit hohem durchsatz (hts) unter verwendung von labormühlen oder microfluidics
|
|
EP1443912B1
(en)
|
2001-10-12 |
2007-08-29 |
Elan Pharma International Limited |
Compositions having a combination of immediate release and controlled release characteristics
|
|
US6407128B1
(en)
|
2001-12-03 |
2002-06-18 |
Elan Pharmaceuticals, Inc. |
Method for increasing the bioavailability of metaxalone
|
|
US7714006B1
(en)
|
2001-12-03 |
2010-05-11 |
King Pharmaceuticals Research & Development, Inc. |
Methods of modifying the bioavailability of metaxalone
|
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
US6825161B2
(en)
|
2002-04-26 |
2004-11-30 |
Salvona Llc |
Multi component controlled delivery system for soap bars
|
|
AU2003276688A1
(en)
|
2002-09-02 |
2004-03-19 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical composition of metaxalone with enhanced oral bioavailability
|
|
JP2004099442A
(ja)
|
2002-09-04 |
2004-04-02 |
Nisshin Pharma Inc |
難溶性薬物含有製剤およびその製造方法
|
|
EP1832582A1
(en)
|
2002-09-30 |
2007-09-12 |
A/S GEA Farmaceutisk Fabrik |
Novel raloxifene malonic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
|
|
DE10250081A1
(de)
*
|
2002-10-25 |
2004-05-13 |
Boehringer Ingelheim Vetmedica Gmbh |
Wasserlösliche Meloxicam Granulate
|
|
US20040173696A1
(en)
|
2002-12-17 |
2004-09-09 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
|
US20040121003A1
(en)
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
|
WO2004066981A1
(en)
|
2003-01-29 |
2004-08-12 |
Sun Pharmaceutical Industries Limited |
Oral controlled release pharmaceutical composition containing metaxalone as active agent
|
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
|
AU2004238321B2
(en)
|
2003-05-07 |
2009-08-27 |
Samyang Biopharmaceuticals Corporation |
Highly plastic granules for making fast melting tablets
|
|
DE60309356T2
(de)
|
2003-06-27 |
2007-08-30 |
Bioprogress S.P.A. |
Zusammensetzung, durch zusammen vermahlen eines wirkstoffes mit einem n-vinyl-2-pyrrolidon/vinylacetatkopolymers erhältlich
|
|
JP2009513512A
(ja)
|
2003-07-09 |
2009-04-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
メロキシカムを含む組成物
|
|
US20050042177A1
(en)
|
2003-07-23 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel compositions of sildenafil free base
|
|
EP1651189B1
(en)
|
2003-08-08 |
2008-12-03 |
Elan Pharma International Limited |
Novel metaxalone compositions
|
|
US9149440B2
(en)
|
2003-09-02 |
2015-10-06 |
University Of South Florida |
Nanoparticles for drug-delivery
|
|
GB0320522D0
(en)
|
2003-09-02 |
2003-10-01 |
Glaxo Group Ltd |
Formulation
|
|
DK1667790T3
(da)
|
2003-10-01 |
2007-09-24 |
Debio Rech Pharma Sa |
Apparat og fremgangsmåde til fremstilling af partikler
|
|
CA2544627A1
(en)
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
|
AU2005221659B2
(en)
|
2004-03-08 |
2008-07-03 |
Spiridon Spireas |
Bioavailable solid dosage forms of metaxalone
|
|
WO2006009825A1
(en)
|
2004-06-17 |
2006-01-26 |
Virun, Inc. |
Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents
|
|
WO2006009419A1
(es)
|
2004-07-19 |
2006-01-26 |
Luis Cordova Boone |
Neumáticos con doble banda de rodamiento
|
|
KR20060024927A
(ko)
|
2004-09-15 |
2006-03-20 |
씨제이 주식회사 |
기계적 분쇄법에 의한 미크론 사이즈 인삼 분말의제조방법
|
|
WO2006041843A2
(en)
|
2004-10-04 |
2006-04-20 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical dosage form comprising meloxicam
|
|
CA2598204C
(en)
|
2004-11-09 |
2015-01-13 |
Board Of Regents, The University Of Texas System |
Stabilized hme composition with small drug particles
|
|
UA89513C2
(uk)
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
|
NZ555719A
(en)
|
2004-12-31 |
2010-11-26 |
Iceutica Pty Ltd |
Nanoparticle composition and methods for synthesis thereof
|
|
US20060246128A1
(en)
|
2005-04-28 |
2006-11-02 |
Wyeth |
Micronized tanaproget and compositions containing same
|
|
JO3352B1
(ar)
|
2005-06-17 |
2019-03-13 |
Apr Applied Pharma Res Sa |
صيغ دايكلوفيناك وطرق استخدامه
|
|
EP1942902A1
(en)
*
|
2005-09-30 |
2008-07-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Pharmaceutical preparation containing meloxicam
|
|
US20080292584A1
(en)
|
2005-10-14 |
2008-11-27 |
Mutual Pharmaceutical Company, Inc. |
Metaxalone products, method of manufacture, and method of use
|
|
EP1978933A2
(en)
|
2005-12-15 |
2008-10-15 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for oral administration
|
|
EP1973523A2
(en)
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
DK1973527T3
(da)
|
2005-12-15 |
2010-02-01 |
Acusphere Inc |
Fremgangsmåder til fremstilling af partikelbaserede farmaceutiske formulationer til parenteral indgivelse
|
|
WO2007074477A2
(en)
|
2005-12-29 |
2007-07-05 |
Dabur Pharma Limited |
Metaxalone polymorphs
|
|
US8420122B2
(en)
|
2006-04-28 |
2013-04-16 |
Merck Sharp & Dohme Corp. |
Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
|
|
KR20090023729A
(ko)
|
2006-06-23 |
2009-03-05 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 멜록시캄 및 조절 방출형 하이드로코돈을 포함하는 조성물
|
|
NZ705763A
(en)
|
2006-06-30 |
2016-10-28 |
Iceutica Pty Ltd |
Methods for the preparation of biologically active compounds in nanoparticulate form
|
|
WO2008000042A1
(en)
|
2006-06-30 |
2008-01-03 |
Iceutica Pty Ltd |
Methods for the preparation of biologically active compounds in nanoparticulate form
|
|
CN100386312C
(zh)
|
2006-07-18 |
2008-05-07 |
上海世景国际贸易有限公司 |
2，4-二氨基苯磺酸及其盐的合成方法
|
|
KR20090027734A
(ko)
|
2006-07-27 |
2009-03-17 |
(주)아모레퍼시픽 |
난용성 약물의 나노입자를 포함하는 분말의 제조방법
|
|
AR065802A1
(es)
|
2007-03-22 |
2009-07-01 |
Schering Corp |
Formulaciones de comprimidos que contienen sales de 8- [( 1- ( 3,5- bis- (trifluorometil) fenil) -etoxi ) - metil) -8- fenil -1, 7- diaza- spiro [ 4,5] decan -2- ona y comprimidos elaborados a partir de estas
|
|
TWI405590B
(zh)
|
2007-04-06 |
2013-08-21 |
Activus Pharma Co Ltd |
微粉碎化有機化合物粒子之製法
|
|
AR067997A1
(es)
|
2007-08-24 |
2009-10-28 |
Novartis Ag |
Compuestos organicos
|
|
RU2010153904A
(ru)
|
2008-06-02 |
2012-07-20 |
Др. Редди'С Лабораторис Лтд. (In) |
Ниацин-содержащие композиции с модифицированным высвобождением
|
|
US8568696B2
(en)
|
2008-08-06 |
2013-10-29 |
Indiana Nanotech Llc |
Grinding method for the manipulation or preservation of calcium phosphate hybrid properties
|
|
AP2015008955A0
(en)
|
2009-04-24 |
2015-12-31 |
Icuetica Pty Ltd |
A novel formulation of indomethacin
|
|
CA2759104C
(en)
|
2009-04-24 |
2019-01-29 |
Iceutica Pty Ltd |
Method for improving the dissolution profile of a biologically active material
|
|
SG175309A1
(en)
|
2009-04-24 |
2011-11-28 |
Iceutica Pty Ltd |
Production of encapsulated nanoparticles at high volume fractions
|
|
NZ706690A
(en)
|
2009-04-24 |
2017-01-27 |
Iceutica Pty Ltd |
A novel formulation of meloxicam
|
|
NZ595903A
(en)
|
2009-04-24 |
2014-03-28 |
Iceutica Pty Ltd |
A novel formulation of metaxalone
|
|
NZ595985A
(en)
|
2009-04-24 |
2014-07-25 |
Iceutica Pty Ltd |
A novel formulation of naproxen
|
|
CN102740835A
(zh)
|
2009-04-24 |
2012-10-17 |
伊休蒂卡有限公司 |
包封的纳米颗粒在工业规模的制备
|
|
MX337619B
(es)
|
2009-04-24 |
2016-03-10 |
Iceutica Pty Ltd |
Una formulacion novedosa de diclofenaco.
|
|
US20120160944A1
(en)
|
2009-04-24 |
2012-06-28 |
Aaron Dodd |
Method for the production of commercial nanoparticle and micro particle powders
|
|
WO2011026080A1
(en)
*
|
2009-08-31 |
2011-03-03 |
Wilmington Pharmaceuticals, Llc |
Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain
|
|
JP6453876B2
(ja)
|
2013-07-22 |
2019-01-16 |
イシューティカ インコーポレイテッド |
メタキサロンの製剤
|
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|